Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia
Open Access
- 30 June 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (9) , 1300-1303
- https://doi.org/10.1016/j.ejca.2005.02.026
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Is the In Vitro Drug Resistance Profile the Strongest Prognostic Factor in Childhood Acute Lymphoblastic Leukemia?Journal of Clinical Oncology, 2004
- Increased in vitro cellular drug resistance is related to poor outcome in high‐risk childhood acute lymphoblastic leukaemiaBritish Journal of Haematology, 2003
- Clinical Significance of Cellular Drug Resistance in Childhood LeukemiaPublished by Springer Nature ,2003
- Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research HospitalLeukemia, 2000
- Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infantsLeukemia, 1998
- In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic LeukemiaBlood, 1997
- Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assayBritish Journal of Cancer, 1994
- Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM groupBlood, 1991